Infection News

In women of reproductive age who have COVID-19, those who are pregnant are more likely to have poor CV outcomes than those who are not, according to a review published in JACC: Advances.

Traditional combined antiretroviral therapy — or cART — and alternative cART were similarly effective in treating HIV-infected pregnant women, with similar rates of vertical transmission, according to a study.

All providers supported administering vaccines that are safe in pregnancy to their pregnant patients, according to a poster presented at the Infectious Diseases Society for Obstetrics and Gynecology Annual Meeting.

Pregnant patients with COVID-19 who were hospitalized for symptomatic disease were more likely to deliver during their stay if they were admitted to the hospital during non-omicron pandemic waves, data showed.

Oteseconazole effectively treated recurrent vulvovaginal candidiasis and prevented acute episodes through 96 weeks, according to data presented at the Infectious Diseases Society for Obstetrics and Gynecology Annual Meeting.

Bavarian Nordic announced today that it has received approval from the FDA to manufacture its monkeypox vaccine Jynneos at the company’s fill and finish facility in Denmark.

In a commentary published in Obstetrics & Gynecology, experts from the CDC and Emory University in Atlanta, Georgia, discussed the clinical implications of the current monkeypox outbreak.

Oral ibrexafungerp had positive outcomes in patients with recurrent vulvovaginal candidiasis who had failed fluconazole treatment, according to a press release from Scynexis.

Compared with women who did not have SARS-CoV-2, those who were infected during the third trimester of pregnancy had a higher risk for preterm birth, data in PLoS One showed.

Linezolid successfully treated pregnant patients with multidrug-resistant tuberculosis, with most patients experiencing favorable pregnancy outcomes, according to a meta-analysis published in JAMA Network Open.